SGH Healthcaring grew out of the merger of three plastics processing firms specialising in medical devices and drug administration for the pharmaceutical industry: Stiplastics, Rovipharm and Eskiss.
Their reputation for know-how - developed over more than 30 years - means they can now offer a comprehensive range, from standard production to tailor-made development and medical subcontracting.
In addition to manufacturing at several facilities certified to ISO 13485 - including cleanrooms - they offer their customers expertise in quality, R&D, industrial production and marketing.
Buyout
Current
Europe
Majority
Life Science Tools, MedTech & Diagnostics
2018
Status
Creation Date
Initial Investment Date
Fund Name
Initial Investment’s Exit Date
Investment Date
Fund Name